Publication:
Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1

Simple item page
dc.contributor.authorMistry, Pramod K. (57211953810)
dc.contributor.authorBalwani, Manisha (22133289200)
dc.contributor.authorBaris, Hagit N. (8608886300)
dc.contributor.authorTurkia, Hadhami Ben (6506812532)
dc.contributor.authorBurrow, T. Andrew (23394581000)
dc.contributor.authorCharrow, Joel (7004262624)
dc.contributor.authorCox, Gerald F. (7402494346)
dc.contributor.authorDanda, Sumita (23026963700)
dc.contributor.authorDragosky, Marta (6507896662)
dc.contributor.authorDrelichman, Guillermo (7801427001)
dc.contributor.authorEl-Beshlawy, Amal (6603278914)
dc.contributor.authorFraga, Cristina (57189444693)
dc.contributor.authorFreisens, Selena (57202019666)
dc.contributor.authorGaemers, Sebastiaan (57191345339)
dc.contributor.authorHadjiev, Evgueniy (57196470542)
dc.contributor.authorKishnani, Priya S. (55574227832)
dc.contributor.authorLukina, Elena (7006788246)
dc.contributor.authorMaison-Blanche, Pierre (55664875900)
dc.contributor.authorMartins, Ana Maria (55695498300)
dc.contributor.authorPastores, Gregory (7005660938)
dc.date.accessioned2025-07-02T12:10:08Z
dc.date.available2025-07-02T12:10:08Z
dc.date.issued2019
dc.description.abstract[No abstract available]
dc.identifier.urihttps://doi.org/10.1016/j.bcmd.2019.04.003
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85064623158&doi=10.1016%2fj.bcmd.2019.04.003&partnerID=40&md5=d0b81b6e8d409ced6269304ca77f241d
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/12704
dc.titleAddendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1
dspace.entity.typePublication

Files

Collections

Publikacije / Publications